<scp>GLP</scp>‐1 Agonists as Potential Neuromodulators in Development of Parkinson's Disease: A Nationwide Cohort Study
Results were suggestive for a potential neuroprotective effect of GLP-1RAs against Parkinson's disease. Further studies are needed to assess biomarkers of disease progression, and evaluate safety in patients with Parkinson's disease, dosing, and effects when combined with other treatments in neurodegenerative diseases.
Authors
- Lina Steinrud Mørch (ORCID: https://orcid.org/0000-0001-6506-2569)
- Amani Meaidi (ORCID: https://orcid.org/0000-0003-4549-8271)
- Mads Gamborg (ORCID: https://orcid.org/0000-0002-9625-2979)
- Mia Klinten Grand (ORCID: https://orcid.org/0000-0003-4691-3203)
- Jasmin Arvedsen
Institutions
- Danish Cancer Society (DK)
Publication Details
- Journal
- European Journal of Neurology
- Published
- 2025-02-01
- DOI
- https://doi.org/10.1111/ene.70075
- Citations
- 5
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 6.47
Funders
- Kræftens Bekæmpelse